Scancell Holdings (SCLP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

15.10p
   
  • Change Today:
      1.10p
  • 52 Week High: 15.50
  • 52 Week Low: 8.54
  • Currency: UK Pounds
  • Shares Issued: 1,037.78m
  • Volume: 2,457,618
  • Market Cap: £156.70m

Company Description

Scancell is a biopharmaceutical company focused on the cancer therapeutics market.

IPO Details

Issue Date 30-Jul-2010 Prospectus n/a
Issue Price n/a Lead Broker Zeus Capital
Market Cap £9.95m Contact Tel 0161 831 1512
Method Introduction    
Sector Pharmaceutical & Biotechnology    
Market Aim    
Amount Raised £0.00m    

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SCLP Market Data

Currency UK Pounds
Share Price 15.10p
Change Today 1.10p
% Change 7.86 %
52 Week High 15.50
52 Week Low 8.54
Volume 2,457,618
Shares Issued 1,037.78m
Market Cap £156.70m

SCLP Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average
18.18% above the sector average18.18% above the sector average18.18% above the sector average18.18% above the sector average18.18% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SCLP Dividends

No dividends found

Trades for 01-May-2026

Time Volume / Share Price
16:35 10,000 @ 15.10p
16:35 500 @ 15.10p
16:35 9,500 @ 15.10p
16:29 7 @ 15.50p
16:29 1,406 @ 15.50p

SCLP Key Personnel

CFO Sath Nirmalananthan
CEO Phil L'Huillier

Top of Page